For: | Fan JG, Zhong L, Tia LY, Xu ZJ, Li MS, Wang GL. Effects of ursodeoxycholic acid and/or low-calorie diet on steatohepatitis in rats with obesity and hyperlipidemia. World J Gastroenterol 2005; 11(15): 2346-2350 [PMID: 15818751 DOI: 10.3748/wjg.v11.i15.2346] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v11/i15/2346.htm |
Number | Citing Articles |
1 |
Monica D. Chow, Yi-Horng Lee, Grace L. Guo. The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. Molecular Aspects of Medicine 2017; 56: 34 doi: 10.1016/j.mam.2017.04.004
|
2 |
Ziwen Wang, Shanshan Li, Ruifeng Wang, Liansheng Guo, Dan Xu, Tieyuan Zhang, Yifan Xu, Wenlong Wang, Min Wang, Zhongwei Gan, Xiaobing Wang. The protective effects of the β3 adrenergic receptor agonist BRL37344 against liver steatosis and inflammation in a rat model of high-fat diet-induced nonalcoholic fatty liver disease (NAFLD). Molecular Medicine 2020; 26(1) doi: 10.1186/s10020-020-00164-4
|
3 |
Karima Begriche, Anissa Igoudjil, Dominique Pessayre, Bernard Fromenty. Mitochondrial dysfunction in NASH: Causes, consequences and possible means to prevent it. Mitochondrion 2006; 6(1): 1 doi: 10.1016/j.mito.2005.10.004
|
4 |
Peter Piringer, Robert Buder, Fritz Firlinger, Christine Kapral, Christian Luft, Wolfgang Sega, Friedrich Wewalka, Kurt Lenz. Steatohepatitis und Leberzirrhose: Erstmanifestation 23 Jahre nach ejunoilealem Bypass. Wiener klinische Wochenschrift 2007; 119(23-24): 733 doi: 10.1007/s00508-007-0850-z
|
5 |
N. Niu, Y. H. Yu, Y. Wang, L. J. Wang, Q. Li, L. M. Guo. Combined effects of niacin and chromium treatment on vascular endothelial dysfunction in hyperlipidemic rats. Molecular Biology Reports 2009; 36(6): 1275 doi: 10.1007/s11033-008-9309-1
|
6 |
Ze-Hua Zhao, Feng-Zhi Xin, Da Zhou, Ya-Qian Xue, Xiao-Lin Liu, Rui-Xu Yang, Qin Pan, Jian-Gao Fan. Trimethylamine N-oxide attenuates high-fat high-cholesterol diet-induced steatohepatitis by reducing hepatic cholesterol overload in rats. World Journal of Gastroenterology 2019; 25(20): 2450-2462 doi: 10.3748/wjg.v25.i20.2450
|
7 |
Abdurrahman Kadayifci, Raphael B. Merriman, Nathan M. Bass. Medical Treatment of Non-alcoholic Steatohepatitis. Clinics in Liver Disease 2007; 11(1): 119 doi: 10.1016/j.cld.2007.02.001
|
8 |
Jian-qing Wang, Yu-hong Zou, Cheng Huang, Chao Lu, Lei Zhang, Yong Jin, Xiong-wen Lü, Li-ping Liu, Jun Li. Protective effects of tiopronin against high fat diet-induced non-alcoholic steatohepatitis in rats. Acta Pharmacologica Sinica 2012; 33(6): 791 doi: 10.1038/aps.2012.19
|
9 |
P Riley, J O’Donohue, M Crook. A growing burden: the pathogenesis, investigation and management of non-alcoholic fatty liver disease. Journal of Clinical Pathology 2007; 60(12): 1384 doi: 10.1136/jcp.2006.044891
|
10 |
Da Zhou, Jian-Gao Fan. Microbial metabolites in non-alcoholic fatty liver disease. World Journal of Gastroenterology 2019; 25(17): 2019-2028 doi: 10.3748/wjg.v25.i17.2019
|
11 |
Shota Sakai, Norihito Iizuka, Mayu Fujiwara, Makoto Miyoshi, Michiko Aoyama, Noriaki Maeshige, Yasuhiro Hamada, Yu Usami, Makoto Usami. Mild obesity reduces survival and adiponectin sensitivity in endotoxemic rats. Journal of Surgical Research 2013; 185(1): 353 doi: 10.1016/j.jss.2013.06.002
|
12 |
Patrícia M. Nunes, John G. Jones, Anabela P. Rolo, Carlos M. M. Palmeira, Rui A. Carvalho. Ursodeoxycholic acid treatment of hepatic steatosis: a 13C NMR metabolic study. NMR in Biomedicine 2011; 24(9): 1145 doi: 10.1002/nbm.1672
|
13 |
Yara Haddad, Diane Vallerand, Antoine Brault, Jean Spénard, Pierre S. Haddad. NCX 1000 Alone or in Combination with Vitamin E Reverses Experimental Nonalcoholic Steatohepatitis in the Rat Similarly to UDCA. International Journal of Hepatology 2011; 2011: 1 doi: 10.4061/2011/136816
|